Adaptive Biotechnologies Corporation conducted its first quarter 2026 earnings conference call on May 5, 2026, at 4:30 PM EDT. Company executives, including CEO Chad Robins and CFO Kyle Piskel, presented financial results and forward-looking statements. The call is available via webcast on the company's investor relations website.
Adaptive Biotechnologies Corporation (ADPT) hosted its Q1 2026 earnings conference call on Monday, May 5, 2026, at 4:30 PM EDT. Karina Calzadilla, Vice President of Investor Relations, opened the proceedings, noting that the company had issued a press release earlier that day with the quarter's financial results. The release is posted at www.adaptivebiotech.com, alongside a slide presentation in the Investors section of the corporate website. A live webcast of the call was also provided there. Key participants from the company included Co-Founder, CEO & Chairman Chad Robins; VP, CFO & Principal Accounting Officer Kyle Piskel; and Chief Commercial Officer of MRD Susan Bobulsky. Analysts from firms such as William Blair, Piper Sandler, BTIG, Guggenheim Securities, JPMorgan Chase, and TD Cowen joined the question-and-answer session. During the call, management made forward-looking statements about future events and financial performance, as protected under federal securities laws. Calzadilla emphasized that these reflect the company's current perspective but actual results may differ materially due to factors outlined in SEC filings and the presentation. The conference was recorded, with operator instructions provided at the start.